STAT Plus: The J&J opioid case in Oklahoma darkens the outlook for other drug companies
PATRICK SISON/AP
"A $572 million verdict against one defendant for one year worth of costs in a state with four million people is not encouraging," wrote one analyst.
No hay comentarios:
Publicar un comentario